Response of Jinjia Shares: Mint-flavored E-cigarettes Mainly Sold to Europe

Business by 2FIRSTS.ai
Jul.01.2024
Response of Jinjia Shares: Mint-flavored E-cigarettes Mainly Sold to Europe
Investors questioned Jinjia Corporation about menthol-flavored e-cigarette products, to which the company stated compliance with regulations for overseas sales.

Recently, an investor asked a question on the investor interaction platform "Interactive Easy" to Jing Jia Stock (002191.SZ): Which subsidiary of the company, Yunnan Changyi or Yunnan Yunshuo, produces products related to Mint Choon?

 

In response, Jinjia Group stated that in accordance with the "Regulations on the Management of E-cigarettes", the sale of flavored e-cigarettes other than tobacco flavor is prohibited domestically. The company's affiliated company, Yunnan Sparking Science and Technology, provides menthol flavoring products to other qualified e-cigarette production enterprises for e-cigarette production, and exports them in finished form overseas, strictly complying with relevant regulations.

 

Investors also asked whether the company's overseas factories produce and sell menthol-flavored e-cigarettes. They inquired about whether the disposable and pod system products also come in menthol flavor, and if these products are being marketed in Europe and the United States. They also wanted to know if the overseas-produced Lono Way Yuet brand e-cigarettes have a mint flavor and which regions they are sold in.

 

Jinjia Group responded that their new tobacco overseas production companies currently provide customers with products such as mint-flavored e-cigarettes that comply with the standards and regulations of the customers' respective countries or regions, primarily sold to European countries.

 

Finally, regarding the positive impact on overseas production and sales of Jinjia brought by the approval of four menthol-flavored e-cigarette by the US FDA last week, Jinjia Group stated that the company is closely monitoring the latest developments in regulations and standards in various countries regarding e-cigarettes. They will strengthen research and development of product diversity and market expansion, and strive to improve sales performance overseas in compliance with local regulations and market access requirements.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Special Report | Russian Vape Compromise Faces First Hurdles
Special Report | Russian Vape Compromise Faces First Hurdles
Russia’s regional vape-ban model is facing early legal and political tests, as Perm Krai moves ahead before federal legislation is fully adopted. The case highlights uncertainty over regional authority, concerns from business groups about market fragmentation, and the risk that pressure against regional bans could revive calls for a stricter nationwide prohibition.
Industry Insight
May.28
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Canada Recalls Siberia and ZYN Nicotine Pouches Over Unauthorized Sales
Health Canada has issued a nationwide recall for nicotine pouch products sold under the Siberia and ZYN brands, citing a lack of market authorization. All affected lots are subject to the recall.
Jun.15
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs Data Show Smokeless Was the Only Growing Major U.S. Nicotine Category
NielsenIQ and Goldman Sachs data show U.S. smokeless nicotine product sales rose more than 8% year over year in the 52 weeks ended May 30, making it the only major nicotine category to record growth.
Market
Jun.23
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
Canada Faces Growing Debate as Youth Nicotine Pouch Use Reaches 34.8%
New Canadian research shows that 34.8% of people aged 17 to 27 have tried nicotine pouches, up more than fourfold from 7.6% in 2022. The findings come as Conservative politicians, Alberta’s government and the tobacco industry push Ottawa to relax current restrictions on pouch sales.
Jun.12